Model-based evaluation of the efficacy and safety of nivolumab once every 4 weeks across multiple tumor types
| Autor: | Zhao, X., Shen, J., Ivaturi, V., Gopalakrishnan, M., Feng, Y., Schmidt, B.J., Statkevich, P., Goodman, V., Gobburu, J., Bello, A., Roy, A., Agrawal, S. |
|---|---|
| Zdroj: | In Annals of Oncology February 2020 31(2):302-309 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|